Related Experiment Video
Updated: Jan 28, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
STAT3beta, a distinct isoform from STAT3
Hui-Xiang Zhang1, Ping-Lian Yang1, En-Min Li2
1The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area, Shantou University Medical College, Shantou 515041, Guangdong, PR China; Institute of Oncological Pathology, Shantou University Medical College, Shantou, Guangdong, PR China.
Abstract:
STAT3β is an isoform of STAT3 (signal transducer and activator of transcription 3) that differs from the STAT3α isoform by the replacement of the C-terminal 55 amino acid residues with 7 specific residues. The constitutive activation of STAT3α plays a pivotal role in the activation of oncogenic pathways, such as cell proliferation, maturation and survival, while STAT3β is often referred to as a dominant-negative regulator of cancer. STAT3β reveals a "spongy cushion" effect through its cooperation with STAT3α or forms a ternary complex with other co-activators. Especially in tumour cells, relatively high levels of STAT3β lead to some favourable changes. However, there are still many mechanisms that have not been clearly explained in contrast to STAT3α, such as STAT3β nuclear retention, more stable heterodimers and the prolonged Y705 phosphorylation. In addition to its transcriptional activities, STAT3β may also function in the cytosol with respect to the mitochondria, cytoskeleton rearrangements and metastasis of cancer cells. In this review, we summarize the mechanisms that underlie the unique roles of STAT3β combined with total STAT3 to enlighten and draw the attention of researchers studying STAT3 and discuss some interesting questions that warrant answers.
Insights
Signal transducer and activator of transcription 3 beta (STAT3β) acts as a cancer regulator. This review explores STAT3β
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- STAT3α activation drives oncogenic pathways.
- STAT3β is a dominant-negative regulator of cancer.
- STAT3β exhibits unique functions distinct from STAT3α.
Purpose of the Study:
- To review the mechanisms of STAT3β's role in cancer.
- To highlight STAT3β's interactions with STAT3α.
- To identify unexplained aspects of STAT3β function.
Main Methods:
- Literature review of STAT3β research.
- Analysis of STAT3β's molecular mechanisms.
- Comparison of STAT3α and STAT3β functions.
Main Results:
- STAT3β can act as a tumor suppressor.
- STAT3β forms complexes influencing cellular processes.
- Unclear mechanisms include nuclear retention and prolonged phosphorylation.
Conclusions:
- STAT3β plays a complex role in cancer, often counteracting STAT3α.
- Further research is needed to elucidate STAT3β's cytosolic functions and regulatory mechanisms.
- Understanding STAT3β is crucial for cancer research and therapeutic strategies.
Related Concept Videos
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Amino acids
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
The Tree of Life - Bacteria, Archaea, Eukaryotes
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...

